INVESTOR NEWS

Apr 24, 2020

2019 Annual Report

The Board of Gentian Diagnostics AS has approved the Annual Report for 2019. The Annual Report is without..

Apr 24, 2020

First quarter 2020 financial report

Moss, 24 April 2020 Gentian Diagnostics AS announces its results for the first quarter of 2020.

Mar 27, 2020

Calprotectin indicates inflammatory response earlier than PCT and CRP

Moss 27.03.2019 Gentian Diagnostics AS is pleased to announce that the results from a study conducted in..

Dec 16, 2019

Financial calendar 2020

Financial calendar for Gentian Diagnostics AS

Dec 05, 2019

Gentian Diagnostics presents at DNB conference in New York

Moss 05.12.19 The CEO of Gentian Diagnostics, Dr. Hilja Ibert, will today give a company presentation at the..

Nov 29, 2019

Share capital increase registered

Reference is made to the stock exchange notice from Gentian Diagnostics AS (the "Company") on 25 November..

Nov 25, 2019

Share Issue in Connection with Employee Share Purchase Program

Reference is made to the annual general meeting held on 28 May 2019 where a resolution to grant an..

Nov 25, 2019

Mandatory Notification of Trade

Reference is made to the stock exchange release 25 November 2019 regarding the Employee Share Purchase..